(45) investigated the potential of urinary exosomal lncRNAs PVT-1, ANRIL, and PCAT-1 as diagnostic biomarkers for bladder cancer, finding significantly higher expression of ANRIL and PCAT-1 in bladder cancer patients compared to healthy controls. The gene discussed is CDKN2B-AS1; the disease is urinary bladder carcinoma.